Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2

被引:40
作者
Cresswell, KS [1 ]
Clarke, CJP [1 ]
Jackson, JT [1 ]
Darcy, PK [1 ]
Trapani, JA [1 ]
Johnstone, RW [1 ]
机构
[1] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia
基金
英国惠康基金; 英国医学研究理事会;
关键词
interferon; HIN-200; tumor suppressor; nuclear localisation; growth;
D O I
10.1016/j.bbrc.2004.11.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The human HTN-200 family member AIM2 was originally identified in a screen for suppressors of melanoma tumorigenicity following introduction of chromosome 6 into the UACC903 human melanoma cell line. Although the AIM2 protein contained many of the conserved structural motifs common to other HIN-200 proteins, the biochemical characteristics of AIM2 and the ability of overexpressed AIM2 to phenocopy the effect of introduction of chromosome 6 in the UACC903 cells had not been assessed. Herein we demonstrated that AIM2 was localised within the nucleus of transfected or interferon-treated human cells. In addition, AIM2 could homodimerise via the amino-terminal (PAAD/DAPIN) region and heterodimerise with the related IFI 16 protein. However, overexpressed AIM2 did not significantly affect the growth or survival of UACC903 cells or another human melanoma cell line. These data indicate that AIM2 has many of the biochemical and structural characteristics of HIN-200 proteins, however, its expression is not sufficient to induce a tumor-suppressor-like phenotype. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:417 / 424
页数:8
相关论文
共 38 条
[1]
A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway [J].
Aglipay, JA ;
Lee, SW ;
Okada, S ;
Fujiuchi, N ;
Ohtsuka, T ;
Kwak, JC ;
Wang, Y ;
Johnstone, RW ;
Deng, CX ;
Qin, J ;
Ouchi, T .
ONCOGENE, 2003, 22 (55) :8931-8938
[2]
The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation [J].
Asefa, B ;
Klarmann, KD ;
Copeland, NG ;
Gilbert, DJ ;
Jenkins, NA ;
Keller, JR .
BLOOD CELLS MOLECULES AND DISEASES, 2004, 32 (01) :155-167
[3]
CLONING AND EXPRESSION OF THE HUMAN MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN - REGULATION BY INTERFERON-ALPHA [J].
BRIGGS, JA ;
BURRUS, GR ;
STICKNEY, BD ;
BRIGGS, RC .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, 49 (01) :82-92
[4]
Inhibition of E2F-mediated transcription by p202 [J].
Choubey, D ;
Li, SJ ;
Datta, B ;
Gutterman, JU ;
Lengyel, P .
EMBO JOURNAL, 1996, 15 (20) :5668-5678
[5]
Inhibition of E2F-4/DP-1-stimulated transcription by p202 [J].
Choubey, D ;
Gutterman, JU .
ONCOGENE, 1997, 15 (03) :291-301
[6]
BINDING OF AN INTERFERON-INDUCIBLE PROTEIN (P202) TO THE RETINOBLASTOMA PROTEIN [J].
CHOUBEY, D ;
LENGYEL, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :6134-6140
[7]
Cytoplasmic localization of the interferon-inducible protein that is encoded by the AIM2 (absent in melanoma) gene from the 200-gene family [J].
Choubey, D ;
Walter, S ;
Geng, YB ;
Xin, H .
FEBS LETTERS, 2000, 474 (01) :38-42
[8]
Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity by p202 [J].
Datta, B ;
Min, W ;
Burma, S ;
Lengyel, P .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) :1074-1083
[9]
THE INTERFERON-INDUCIBLE AUTOANTIGEN, IFI-16 - LOCALIZATION TO THE NUCLEOLUS AND IDENTIFICATION OF A DNA-BINDING DOMAIN [J].
DAWSON, MJ ;
TRAPANI, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 214 (01) :152-162
[10]
Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma [J].
DeYoung, KL ;
Ray, ME ;
Su, YA ;
Anzick, SL ;
Johnstone, RW ;
Trapani, JA ;
Meltzer, PS ;
Trent, JM .
ONCOGENE, 1997, 15 (04) :453-457